Secondary structure and interfacial aggregation of amyloid-β(1-40) on sodium dodecyl sulfate micelles

Biochemistry

Volumn 45, Issue 28, 2006, Pages 8639-8648

  Rangachari, Vijayaraghavan ^a   Reed, Dana Kim ^a   Moore, Brenda D ^a   Rosenberry, Terrone L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; BIOLOGICAL MEMBRANES; BRAIN; FLUORESCENCE; MICELLES; MOLECULAR STRUCTURE;

ALZHEIMER'S DISEASE (AD); FIBRILS; INTERFACIAL AGGREGATION; SENILE PLAQUES;

NEUROLOGY;

AMYLOID BETA PROTEIN[1-40]; DODECYL SULFATE SODIUM; HEXAFLUORO 2 PROPANOL; THIOFLAVINE;

ALZHEIMER DISEASE; ARTICLE; CIRCULAR DICHROISM; FLUORESCENCE; MICELLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; CIRCULAR DICHROISM; HUMANS; MICELLES; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROPANOLS; PROTEIN STRUCTURE, SECONDARY; SODIUM DODECYL SULFATE;

EID: 33746095813     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060323t     Document Type: Article

References (62)

1. Cohen, A. S., and Calkins, E. (1959) Electron microscopic observation on a fibrous component in amyloid of diverse origins, Nature 183, 1202-1203.
2. Glenner, G. G., and Wong, C. W. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun. 120, 885-890.
3. Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., and Iqbal, K. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease, Arch. Biochem. Biophys. 301, 41-52.
4. Selkoe, D. J. (2001) Alzheimer's disease: Genes, proteins, and therapy, Physiol. Rev. 81, 741-766.
5. Hardy, J. A., and Higgins, G. A. (1992) Alzheimer's disease: The amyloid cascade hypothesis, Science 256, 184-185.
6. Selkoe, D. J., and Podlisny, M. B. (2002) Deciphering the genetic basis of Alzheimer's disease, Annu. Rev. Genomics Hum. Genet. 3, 67-99.
7. Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., Naslund, J., and Lannfelt, L. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation, Nat. Neurosci. 4, 887-893.
8. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science 297, 353-356.
9. Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., and Selkoe, D. J. (1999) Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons, J. Neurosci. 19, 8876-8884.
10. Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small Aβ oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224.
11. Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., and Ashe, K. H. (2002) The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci. 22, 1858-1867.
12. Kawarabayashi, T., Shoji, M., Younkin, L. H., Lin, W. L., Dickson, D. W., Murakami, T., Matsubara, E., Abe, K., Ashe, K. H., and Younkin, S. G. (2004) Dimeric amyloid β protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci. 24, 3801-3809.
13. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., Bush, A. I., and Masters, C. L. (1999) Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol. 46, 860-866.
14. Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture, J. Biol. Chem. 270, 9564-9570.
15. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416, 535-539.
16. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid β protein specifically disrupt cognitive function, Nat. Neurosci. 8, 79-84.
17. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis: Detection of a protofibrillar intermediate, J. Biol. Chem. 272, 22364-22372.
18. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., and Teplow, D. B. (1999) Amyloid β-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates, J. Biol. Chem. 274, 25945-25952.
19. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1997) Observation of metastable Aβ amyloid protofibrils by atomic force microscopy, Chem. Biol. 4, 119-125.
20. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1999) Assembly of Aβ amyloid peptides: An in vitro model for a possible early event in Alzheimer's disease, Biochemistry 38, 8972-8980.
21. Goldsbury, C. S., Wirtz, S., Muller, S. A., Sunderji, S., Wicki, P., Aebi, U., and Frey, P. (2000) Studies on the in vitro assembly of Aβ 1-40: Implications for the search for Aβ fibril formation inhibitors, J. Struct. Biol. 130, 217-231.
22. Huang, T. H., Yang, D. S., Plaskos, N. P., Go, S., Yip, C. M., Fraser, P. E., and Chakrabartty, A. (2000) Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide, J. Mol. Biol. 297, 73-87.
23. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability, J. Biol. Chem. 277, 32046-32053.
24. Nichols, M. R., Moss, M. A., Reed, D. K., Lin, W.-L., Mukhopadhyay, R., Hoh, J. H., and Rosenberry, T. L. (2002) Growth of β-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy, Biochemistry 41, 6115-6127.
25. 1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453.
26. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-assembly of Aβ(1-42) into globular neurotoxins, Biochemistry 42, 12749-12760.
27. Stine, W. B. J., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis, J. Biol. Chem. 278, 11612-11622.
28. Simons, K., and Vaz, W. L. (2004) Model systems, lipid rafts, and cell membranes, Annu. Rev. Biophys. Biomol. Struct. 33, 269-295.
29. Riddell, D. R., Christie, G., Hussain, I., and Dingwall, C. (2001) Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts, Curr. Biol. 11, 1288-1293.
30. Wahrle, S., Das, P., Nyborg, A. C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L. H., Younkin, S. G., and Golde, T. E. (2002) Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains, Neurobiol. Dis. 9, 11-23.
31. Lee, S. J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury, P. T., Jr., and Kosik, K. S. (1998) A detergent-insoluble membrane compartment contains Aβ in vivo, Nat. Med. 4, 730-734.
32. Choo-Smith, L. P., Garzon-Rodriguez, W., Glabe, C. G., and Surewicz, W. K. (1997) Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles, J. Biol. Chem. 272, 22987-22990.
33. Choo-Smith, L. P., and Surewicz, W. K. (1997) The interaction between Alzheimer amyloid β(1-40) peptide and ganglioside GM1-containing membranes, FEBS Lett. 402, 95-98.
34. Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. (2002) Interactions of amyloid β-protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid, Biochemistry 41, 7385-7390.
35. Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., and Teplow, D. B. (1996) On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantification of rate constants, Proc. Natl. Acad. Sci. U.S.A. 93, 1125-1129.
36. Tjernberg, L. O., Pramanik, A., Bjorling, S., Thyberg, P., Thyberg, J., Nordstedt, C., Berndt, K. D., Terenius, L., and Rigler, R. (1999) Amyloid β-peptide polymerization studied using fluorescence correlation spectroscopy, Chem. Biol. 6, 53-62.
37. Yong, W., Lomakin, A., Kirkitadze, M. D., Teplow, D. B., Chen, S. H., and Benedek, G. B. (2001) Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering, Proc. Natl. Acad. Sci. U.S.A. 99, 150-154.
38. Pratt, L. R., and Pohorille, A. (2002) Hydrophobic effects and modeling of biophysical aqueous solution interfaces, Chem. Rev. 102, 2671-2692.
39. Schladitz, C., Vieira, E. P., Hermel, H., and Mohwald, H. (1999) Amyloid-β-sheet formation at the air-water interface, Biophys. J. 77, 3305-3310.
40. Nichols, M. R., Moss, M. A., Reed, D. K., Hoh, J. H., and Rosenberry, T. L. (2005) Rapid assembly of amyloid-β peptide at a liquid/liquid interface produces unstable β-sheet fibers, Biochemistry 44, 165-173.
41. Nichols, M. R., Moss, M. A., Reed, D. K., Cratic-McDaniel, S., Hoh, J. H., and Rosenberry, T. L. (2005) Amyloid-β protofibrils differ from amyloid-β aggregates induced in dilute hexafluoroisopropanol in stability and morphology, J. Biol. Chem. 280, 2471-2480.
42. Terzi, E., Holzemann, G., and Seelig, J. (1997) Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes, Biochemistry 36, 14845-14852.
43. Matsuzaki, K., and Horikiri, C. (1999) Interactions of amyloid β-peptide(1-40) with ganglioside-containing membranes, Biochemistry 38, 4137-4142.
44. Yip, C. M., and McLaurin, J. (2001) Amyloid-β peptide assembly: A critical step in fibrillogenesis and membrane disruption, Biophys. J. 80, 1359-1371.
45. Yamamoto, N., Hasegawa, K., Matsuzaki, K., Naiki, H., and Yanagisawa, K. (2004) Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid β-protein, J. Neurochem. 90, 62-69.
46. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P., and Craik, D. J. (1998) Solution structure of amyloid β-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 37, 11064-11077.
47. Shao, H., Jao, S., Ma, K., and Zagorski, M. G. (1999) Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer's disease, J. Mol. Biol. 285, 755-773.
48. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N., and Fink, A. L. (2001) Probing the mechanism of insulin fibril formation with insulin mutants, Biochemistry 40, 8397-8409.
49. LeVine, H. (1993) Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution, Protein Sci. 2, 404-410.
50. Henry, G. D., and Sykes, B. D. (1994) Methods to study membrane protein structure in solution, Methods Enzymol. 239, 515-535.
51. Reynolds, J. A., and Tanford, C. (1970) The gross conformation of protein-sodium dodecyl sulfate complexes, J. Biol. Chem. 245, 5161-5165.
52. 1-40 peptide in water: Uncoupling β-structure folding from aggregation, Biochim. Biophys. Acta 1476, 93-102.
53. Kirkitadze, M. D., Condron, M. M., and Teplow, D. B. (2001) Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis, J. Mol. Biol. 312, 1103-1119.
54. Barrow, C. J., Yasuda, A., Kenny, P. T., and Zagorski, M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra, J. Mol. Biol. 225, 1075-1093.
55. Soto, C., and Frangione, B. (1995) Two conformational states of amyloid β-peptide: Implications for the pathogenesis of Alzheimer's disease, Neurosci. Lett. 186, 115-118.
56. Jarrett, J. T., and Lansbury, P. T., Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
57. Makin, O. S., and Serpell, L. C. (2002) Examining the structure of the mature amyloid fibril, Biochem. Soc. Trans. 30, 521-525.
58. Pertinhez, T. A., Bouchard, M., Smith, R. A., Dobson, C. M., and Smith, L. J. (2002) Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS, FEBS Lett. 529, 193-197.
59. Yamamoto, S., Hasegawa, K., Yamaguchi, I., Tsutsumi, S., Kardos, J., Goto, Y., Gejyo, F., and Naiki, H. (2004) Low concentrations of sodium dodecyl sulfate induce the extension of β2-microglobulin-related amyloid fibrils at a neutral pH, Biochemistry 43, 11075-11082.
60. Daban, J. R., Samso, M., and Bartolome, S. (1991) Use of Nile red as a fluorescent probe for the study of the hydrophobic properties of protein-sodium dodecyl sulfate complexes in solution, Anal. Biochem. 199, 162-168.
61. Santos, S. F., Zanette, D., Fischer, H., and Itri, R. (2003) A systematic study of bovine serum albumin (BSA) and sodium dodecyl sulfate (SDS) interactions by surface tension and small-angle X-ray scattering, J. Colloid Interface Sci. 262, 400-408.
62. Turro, N. J., Lei, X. G., Ananthapadmanabhan, K. P., and Aronson, M. (1995) Spectroscopic probe analysis of protein-surfactant interactions: The BSA/SDS system, Langmuir 11, 2525-2533.